The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-tert-Butyl-3-[3-(3,5-dimethoxy-phenyl)-7-(3-morpholin-4-yl-propylamino)-[1,6]naphthyridin-2-yl]-urea ID: ALA339856
PubChem CID: 5329004
Max Phase: Preclinical
Molecular Formula: C28H38N6O4
Molecular Weight: 522.65
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCOCC4)cc3nc2NC(=O)NC(C)(C)C)c1
Standard InChI: InChI=1S/C28H38N6O4/c1-28(2,3)33-27(35)32-26-23(19-13-21(36-4)16-22(14-19)37-5)15-20-18-30-25(17-24(20)31-26)29-7-6-8-34-9-11-38-12-10-34/h13-18H,6-12H2,1-5H3,(H,29,30)(H2,31,32,33,35)
Standard InChI Key: QNIMLRHYPMIYSE-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
2.6000 -1.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3167 -1.6125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8875 -1.6167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5917 -0.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3167 -2.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3042 0.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1667 -1.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8792 0.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1667 -0.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4542 -1.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2583 -0.3792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2583 -1.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0375 -2.8500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4083 -4.1000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3000 0.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0167 -0.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4542 0.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6042 -2.8542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7292 0.8708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7292 0.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0042 1.2833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0375 -3.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8375 -4.9167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9750 -1.6250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0000 2.1083 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4500 -0.3625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6958 -3.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6875 -2.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4125 -4.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1250 -3.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9750 -2.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1208 -5.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8458 -4.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7542 -4.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8167 -4.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3250 -4.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7042 2.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4542 -1.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 1 1 0
5 2 1 0
6 4 1 0
7 3 1 0
8 4 2 0
9 8 1 0
10 7 2 0
11 17 1 0
12 10 1 0
13 5 1 0
14 27 1 0
15 6 1 0
16 6 2 0
17 9 2 0
18 5 2 0
19 20 2 0
20 16 1 0
21 15 2 0
22 13 1 0
23 33 1 0
24 12 1 0
25 21 1 0
26 20 1 0
27 28 1 0
28 31 1 0
29 14 1 0
30 14 1 0
31 24 1 0
32 29 1 0
33 30 1 0
34 22 1 0
35 22 1 0
36 22 1 0
37 25 1 0
38 26 1 0
7 9 1 0
21 19 1 0
12 11 2 0
32 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 522.65Molecular Weight (Monoisotopic): 522.2955AlogP: 4.37#Rotatable Bonds: 9Polar Surface Area: 109.87Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.59CX Basic pKa: 7.00CX LogP: 2.95CX LogD: 2.80Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.36Np Likeness Score: -1.18
References 1. Thompson AM, Connolly CJ, Hamby JM, Boushelle S, Hartl BG, Amar AM, Kraker AJ, Driscoll DL, Steinkampf RW, Patmore SJ, Vincent PW, Roberts BJ, Elliott WL, Klohs W, Leopold WR, Showalter HD, Denny WA.. (2000) 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase., 43 (22): [PMID:11063616 ] [10.1021/jm000161d ] 2. Thompson AM, Delaney AM, Hamby JM, Schroeder MC, Spoon TA, Crean SM, Showalter HD, Denny WA.. (2005) Synthesis and structure-activity relationships of soluble 7-substituted 3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-amines and related ureas as dual inhibitors of the fibroblast growth factor receptor-1 and vascular endothelial growth factor receptor-2 tyrosine kinases., 48 (14): [PMID:16000000 ] [10.1021/jm0500931 ]